Amrutanjan Health Care Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Sambhu Sivalenka
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 25.3yrs |
| Participación del CEO | 13.9% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 3yrs |
Actualizaciones recientes de la dirección
Recent updates
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹440m |
| Sep 30 2023 | n/a | n/a | ₹373m |
| Jun 30 2023 | n/a | n/a | ₹432m |
| Mar 31 2023 | n/a | n/a | ₹398m |
| Dec 31 2022 | n/a | n/a | ₹418m |
| Sep 30 2022 | n/a | n/a | ₹517m |
| Jun 30 2022 | n/a | n/a | ₹588m |
| Mar 31 2022 | n/a | n/a | ₹672m |
| Dec 31 2021 | n/a | n/a | ₹627m |
| Sep 30 2021 | n/a | n/a | ₹631m |
| Jun 30 2021 | n/a | n/a | ₹668m |
| Mar 31 2021 | n/a | n/a | ₹612m |
| Dec 31 2020 | n/a | n/a | ₹589m |
| Sep 30 2020 | n/a | n/a | ₹474m |
| Jun 30 2020 | n/a | n/a | ₹322m |
| Mar 31 2020 | ₹13m | ₹11m | ₹251m |
| Dec 31 2019 | n/a | n/a | ₹314m |
| Sep 30 2019 | n/a | n/a | ₹274m |
| Jun 30 2019 | n/a | n/a | ₹257m |
| Mar 31 2019 | ₹13m | ₹11m | ₹250m |
| Dec 31 2018 | n/a | n/a | ₹158m |
| Sep 30 2018 | n/a | n/a | ₹168m |
| Jun 30 2018 | n/a | n/a | ₹201m |
| Mar 31 2018 | ₹13m | ₹11m | ₹200m |
Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Sambhu es razonable en comparación con empresas de tamaño similar en el mercado Indian.
Compensación vs. Ingresos: La compensación de Sambhu ha sido consistente con los resultados de la empresa en el último año.
CEO
Sambhu Sivalenka (49 yo)
25.3yrs
Permanencia
₹12,759,000
Compensación
Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Executive Chairman since February 13, 2012. He has been Director...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & MD | 25.3yrs | ₹12.76m | 13.94% ₹ 3.0b | |
| Independent Non-Executive Director | 3yrs | ₹1.26m | sin datos | |
| Non-Executive Non Independent Director | less than a year | sin datos | 3.02% ₹ 653.8m | |
| Non-Executive Independent Director | 9yrs | ₹1.26m | 0.12% ₹ 26.6m | |
| Non-Executive Independent Director | 2.9yrs | ₹1.03m | sin datos | |
| Additional Non-Executive Independent Director | 1.8yrs | ₹484.00k | sin datos |
3.0yrs
Permanencia media
64.5yo
Promedio de edad
Junta con experiencia: La junta directiva de AMRUTANJAN no se considera experimentada (2.9 años de permanencia promedio), lo que sugiere una nueva junta directiva.